{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:24:46Z","timestamp":1790691886381,"version":"4.1.0"},"reference-count":226,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:p>Cells exhibiting embryonic stem cell (ESC) characteristics have been demonstrated in vascular anomalies (VAs), cancer, and fibroproliferative conditions, which are commonly managed by plastic surgeons and remain largely unsolved. The efficacy of the mTOR inhibitor sirolimus, and targeted therapies that block the Ras\/BRAF\/MEK\/ERK1\/2 and PI3KCA\/AKT\/mTOR pathways in many types of cancer and VAs, further supports the critical role of ESC-like cells in the pathogenesis of these conditions. ESC-like cells in VAs, cancer, and fibroproliferative conditions express components of the renin-angiotensin system (RAS) \u2013 a homeostatic endocrine signaling cascade that regulates cells with ESC characteristics. ESC-like cells are influenced by the Ras\/BRAF\/MEK\/ERK1\/2 and PI3KCA\/AKT\/mTOR pathways, which directly regulate cellular proliferation and stemness, and interact with the RAS at multiple points. Gain-of-function mutations affecting these pathways have been identified in many types of cancer and VAs, that have been treated with targeted therapies with some success. In cancer, the RAS promotes tumor progression, treatment resistance, recurrence, and metastasis. The RAS modulates cellular invasion, migration, proliferation, and angiogenesis. It also indirectly regulates ESC-like cells via its direct influence on the tissue microenvironment and by its interaction with the immune system.<jats:italic>In vitro<\/jats:italic>studies show that RAS inhibition suppresses the hallmarks of cancer in different experimental models. Numerous epidemiological studies show a reduced incidence of cancer and improved survival outcomes in patients taking RAS inhibitors, although some studies have shown no such effect. The discovery of ESC-like cells that express RAS components in infantile hemangioma (IH) underscores the paradigm shift in the understanding of its programmed biologic behavior and accelerated involution induced by \u03b2-blockers and angiotensin-converting enzyme inhibitors. The findings of SOX18 inhibition by R-propranolol suggests the possibility of targeting ESC-like cells in IH without \u03b2-adrenergic blockade, and its associated side effects. This article provides an overview of the current knowledge of ESC-like cells and the RAS in VAs, cancer, and fibroproliferative conditions. It also highlights new lines of research and potential novel therapeutic approaches for these unsolved problems in plastic surgery, by targeting the ESC-like cells through manipulation of the RAS, its bypass loops and converging signaling pathways using existing low-cost, commonly available, and safe oral medications.<\/jats:p>","DOI":"10.3389\/fsurg.2022.868187","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T07:29:59Z","timestamp":1651044599000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Insights Into Vascular Anomalies, Cancer, and Fibroproliferative Conditions: The Role of Stem Cells and the Renin-Angiotensin System"],"prefix":"10.3389","volume":"9","author":[{"given":"Ethan J.","family":"Kilmister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swee T.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fsurg.2020.610758","article-title":"Cell populations expressing stemness- associated markers in vascular anomalies","volume":"7","author":"Kilmister","year":"2021","journal-title":"Front Surg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3389\/fonc.2019.00745","article-title":"Therapeutic targeting of cancer stem cells via modulation of the renin-angiotensin system","volume":"9","author":"Roth","year":"2019","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3390\/cells8111364","article-title":"Therapeutic targeting of cancer stem cells in human glioblastoma by manipulating the renin-angiotensin system","volume":"8","author":"Tan","year":"2019","journal-title":"Cells"},{"key":"B5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1369\/00221554211026295","article-title":"The role of the renin\u2013angiotensin system in the cancer stem cell niche","volume":"69","author":"Kilmister","year":"2021","journal-title":"J Histochem Cytochem"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-88334-8_2","article-title":"Cancer stem cells in head and neck cancers","author":"Kilmister","year":"2022","journal-title":"Atlas of Extreme Facial Cancer Springer Nature AG"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/GOX.0000000000001777","article-title":"The role of stem cells in dupuytren's disease: a review","author":"Tan","year":"2018","journal-title":"Plast Reconstr Surg - Glob Open"},{"key":"B8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fsurg.2019.00067","article-title":"The role of the renin-angiotensin system and vitamin D in keloid disorder-a review","volume":"6","author":"Kilmister","year":"2019","journal-title":"Front Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2228","DOI":"10.1097\/GOX.0000000000002228","article-title":"Stem cells in keloid lesions: a review","volume":"7","author":"Lim","year":"2019","journal-title":"Plast Reconstr Surg - Glob Open"},{"key":"B10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/292154a0","article-title":"Establishment in culture of pluripotential cells from mouse embryos","volume":"292","author":"Evans","year":"1981","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3389\/fonc.2020.01091","article-title":"Cancer stem cell subpopulations are present within metastatic head and neck cutaneous squamous cell carcinoma","volume":"10","author":"Kilmister","year":"2020","journal-title":"Front Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fsurg.2014.00038","article-title":"Biology of infantile hemangioma","volume":"1","author":"Itinteang","year":"2014","journal-title":"Front Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/cup.12786","article-title":"Expression of embryonic stem cell markers in pyogenic granuloma","volume":"43","author":"Blackwell","year":"2016","journal-title":"J Cutan Pathol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fsurg.2021.621089","article-title":"Stemness-associated markers are expressed in extracranial arteriovenous malformation","volume":"8","author":"Luke Krishnan","year":"2021","journal-title":"Front Surg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fmed.2017.00162","article-title":"Embryonic stem cell-like subpopulations in venous malformation","volume":"4","author":"Tan","year":"2017","journal-title":"Front Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/cup.12078","article-title":"Verrucous hemangioma expresses primitive markers","volume":"40","author":"Laing","year":"2013","journal-title":"J Cutan Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e006","DOI":"10.1097\/JOVA.0000000000000006","article-title":"Embryonic stem cell-like population in hypertrophic port-wine stain","volume":"2","author":"Williams","year":"2021","journal-title":"J Vasc Anomalies"},{"key":"B19","first-page":"3027","article-title":"Keloid-associated lymphoid tissues in keloid lesions express vitamin D receptor","volume":"12","author":"Kilmister","year":"2019","journal-title":"Int J Clin Exp Pathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/jclinpath-2015-203483","article-title":"Expression of embryonic stem cell markers in keloid-associated lymphoid tissue","volume":"69","author":"Grant","year":"2016","journal-title":"J Clin Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1064","DOI":"10.1097\/GOX.0000000000001064","article-title":"Embryonic stem cell-like population in Dupuytren's disease","volume":"4","author":"Koh","year":"2016","journal-title":"Plast Reconstr Surg - Glob Open"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0221963","DOI":"10.1371\/journal.pone.0221963","article-title":"Cancer stem cell subpopulations in primary colon adenocarcinoma","volume":"14","author":"Munro","year":"2019","journal-title":"PLoS ONE"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/life11101106","article-title":"Cell populations expressing stemness-associated markers in lung adenocarcinoma","volume":"11","author":"Paterson","year":"2021","journal-title":"Life"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fsurg.2016.00021","article-title":"Cancer stem cell hierarchy in glioblastoma multiforme","volume":"3","author":"Bradshaw","year":"2016","journal-title":"Front Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/jclinpath-2015-203599","article-title":"Cancer stem cells in moderately differentiated oral tongue squamous cell carcinoma","volume":"69","author":"Baillie","year":"2016","journal-title":"J Clin Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fsurg.2017.00076","article-title":"Characterization of cancer stem cells in colon adenocarcinoma metastasis to the liver","author":"Humphries","year":"2018","journal-title":"Front Surg"},{"key":"B27","first-page":"6","article-title":"Brasch HD, Savage S, Marsh RW, Itinteang T, Tan ST, Itinteang T. Characterization of cancer stem cells in renal clear cell carcinoma","volume":"5","author":"Cane","year":"2019","journal-title":"J Stem Cell Regen Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fsurg.2017.00012","article-title":"The identification of three cancer stem cell subpopulations within moderately differentiated lip squamous cell carcinoma","author":"Ram","year":"2017","journal-title":"Front Surg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fsurg.2016.00046","article-title":"Characterization of cancer stem cells in moderately differentiated buccal mucosal squamous cell carcinoma","volume":"3","author":"Yu","year":"2016","journal-title":"Front Surg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.heliyon.2019.e02257","article-title":"Cancer stem cell subpopulations in moderately differentiated head and neck cutaneous squamous cell carcinoma","author":"Koh","year":"2019","journal-title":"Heliyon"},{"key":"B31","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/cells9020324","article-title":"Identification of cancer stem cell subpopulations in head and neck metastatic malignant melanoma","volume":"9","author":"Yoganandarajah","year":"2020","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jocn.2018.10.068","article-title":"Expression of cancer stem cell markers in metastatic melanoma to the brain","volume":"60","author":"Wickremesekera","year":"2019","journal-title":"J Clin Neurosci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/cells10020243","article-title":"Cancer stem cells in metastatic head and neck cutaneous squamous cell carcinoma express components of the renin-angiotensin system","author":"Siljee","year":"2021","journal-title":"Cells"},{"key":"B34","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/jclinpath-2016-203736","article-title":"Cancer stem cells in moderately differentiated oral tongue squamous cell carcinoma express components of the renin\u2013angiotensin system","volume":"69","author":"Itinteang","year":"2016","journal-title":"J Clin Pathol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.3390\/cancers13164004","article-title":"The renin\u2013angiotensin system in the tumor microenvironment of glioblastoma","volume":"13","author":"O'Rawe","year":"2021","journal-title":"Cancers"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/GOX.0000000000001422","article-title":"Embryonic stem cell-like population in Dupuytren's disease expresses components of the renin-angiotensin system","author":"On","year":"2017","journal-title":"Plast Reconstr Surg - Glob Open"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1097\/00006123-199706000-00005","article-title":"Ethanol endovascular management of brain arteriovenous malformations: Initial results","volume":"40","author":"Yakes","year":"1997","journal-title":"Neurosurgery"},{"key":"B38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/jcdd6020014","article-title":"An Update on the tissue renin angiotensin System and its role in physiology and pathology","volume":"6","author":"Nehme","year":"2019","journal-title":"J Cardiovasc Dev Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.18553\/jmcp.2007.13.s8-b.9","article-title":"The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition","author":"Atlas","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"B40","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0024-3205(82)90272-7","article-title":"Hormonal control of angiotensinogen production","volume":"30","author":"Dzau","year":"1982","journal-title":"Life Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s12094-020-02488-3","article-title":"Renin-angiotensin system and cancer: epidemiology, cell signaling, genetics and epigenetics","volume":"23","author":"Afsar","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41581-019-0160-5","article-title":"The (pro)renin receptor in health and disease","volume":"15","author":"Ichihara","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1152\/ajprenal.1984.247.2.F205","article-title":"Potential effects of renin activation on the regulation of renin production","author":"Hsueh","year":"1984","journal-title":"Am J Physiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1113\/expphysiol.2008.042002","article-title":"Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis","volume":"93","author":"Santos","year":"2008","journal-title":"Exp Physiol Artic"},{"key":"B45","first-page":"11","article-title":"Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases","volume":"52","author":"Kim","year":"2000","journal-title":"Pharmacol Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.1111\/febs.12509","article-title":"Unravelling the molecular complexity of GPCR-mediated EGFR transactivation using functional genomics approaches","volume":"280","author":"George","year":"2013","journal-title":"FEBS J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1055\/s-0031-1291272","article-title":"Aldosterone does not modify gene expression in human endothelial cells","volume":"44","author":"Verhovez","year":"2012","journal-title":"Horm Metab Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/1470320309347791","article-title":"The past, present and future of angiotensin II type 2 receptor stimulation","volume":"11","author":"Steckelings","year":"2010","journal-title":"JRAAS - J Renin-Angiotensin-Aldosterone Syst"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms19030876","article-title":"Within the brain: the renin angiotensin system","volume":"19","author":"Jackson","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fphys.2017.00276","article-title":"The ACE2\/Angiotensin-(1\u20137)\/Mas receptor axis: pleiotropic roles in cancer","volume":"8","author":"Xu","year":"2017","journal-title":"Front Physiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.3892\/ol.2017.6826","article-title":"Renin angiotensin system deregulation as renal cancer risk factor","volume":"14","author":"Sobczuk","year":"2017","journal-title":"Oncol Lett"},{"key":"B53","doi-asserted-by":"publisher","first-page":"770","DOI":"10.4149\/neo_2021_201213N1347","article-title":"The role of angiotensin-(1-7) on acquired platinum resistance-induced angiogenesis in non-small cell lung cancer in vitro and in vivo","volume":"68","author":"Geng","year":"2021","journal-title":"Neoplasma"},{"key":"B54","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s40292-015-0120-5","article-title":"SIIA Task Force, Rossi F, SIF Task Force. Role of the renin-angiotensin-aldosterone system and its pharmacological inhibitors in cardiovascular diseases: complex and critical issues High Blood Press","volume":"22","author":"Borghi","year":"2015","journal-title":"Cardiovasc Prev"},{"key":"B55","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fsurg.2019.00006","article-title":"Expression of cathepsins B, D, and G in WHO grade i meningioma","volume":"6","author":"Rahman","year":"2019","journal-title":"Front Surg"},{"key":"B56","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2147\/VHRM.S1905","article-title":"dos, Silva ACS. The renin\u2013angiotensin system and diabetes: an update","volume":"4","author":"Ribeiro-Oliveira","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"B57","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/kisup.2014.11","article-title":"Key fibrogenic mediators: old players. Renin-angiotensin system Kidney","volume":"4","author":"Macconi","year":"2014","journal-title":"Int Suppl"},{"key":"B58","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.yjmcc.2015.11.027","article-title":"Persistent phenotypic shift in cardiac fibroblasts: impact of transient renin angiotensin system inhibition","volume":"93","author":"Hale","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.phrs.2016.03.018","article-title":"ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis","volume":"107","author":"Sim\u00f5es e Silva","year":"2016","journal-title":"Pharmacol Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.biocel.2011.11.019","article-title":"Angiotensin signalling in pulmonary fibrosis","volume":"44","author":"Uhal BD Li","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1042\/CS20120030","article-title":"Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options","volume":"123","author":"Grace","year":"2012","journal-title":"Clin Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1159\/000342776","article-title":"The renin-angiotensin system in the pathophysiology of type 2 diabetes","volume":"5","author":"Goossens","year":"2012","journal-title":"Obes Facts"},{"key":"B63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15406\/jlprr.2018.05.00160","article-title":"The renin angiotensin system in liver and lung: impact and therapeutic potential in organ fibrosis","author":"Abdul-Hafez","year":"2018","journal-title":"J lung, Pulm Respir Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1042\/CS20120300","article-title":"Local bone marrow renin-angiotensin system in primitive, definitive and neoplastic haematopoiesis","volume":"124","author":"Haznedaroglu","year":"2013","journal-title":"Clin Sci"},{"key":"B65","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00277-004-0989-x","article-title":"Local umbilical cord blood renin-angiotensin system","volume":"84","author":"Goker","year":"2005","journal-title":"Ann Hematol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1054\/mehy.1998.0830","article-title":"A unifying hypothesis for the renin-angiotensin system and hematopoiesis: sticking the pieces together with the JAK-STAT pathway","volume":"54","author":"Haznedaroglu","year":"2000","journal-title":"Med Hypotheses"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1080\/1042819021000040080","article-title":"Renin expression in hematological malignancies and its role in the regulation of hematopoiesis","volume":"43","author":"Casares","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"B68","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nrc2945","article-title":"The renin\u2013angiotensin system and cancer: old dog, new tricks","volume":"10","author":"George","year":"2010","journal-title":"Nat Rev Cancer 2010 1011"},{"key":"B69","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1126\/scitranslmed.aan5616","article-title":"Targeting the renin-angiotensin system to improve cancer treatment: implications for immunotherapy","volume":"9","author":"Pinter","year":"2017","journal-title":"Sci Transl Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/medicina56010015","article-title":"Tumor microenvironment","volume":"56","author":"Arneth","year":"2019","journal-title":"Medicina"},{"key":"B71","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B72","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-981-15-9762-6_4","article-title":"Classification: general overview","author":"Lee","year":"2021","journal-title":"Vasc Malformations"},{"key":"B73","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1055\/s-0044-101266","article-title":"Vascular anomalies (part II): interventional therapy of peripheral vascular malformations","volume":"190","author":"M\u00fcller-Wille","year":"2018","journal-title":"Rofo"},{"key":"B74","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/jclinpath-2011-200462","article-title":"Infantile haemangioma expresses embryonic stem cell markers","volume":"65","author":"Itinteang","year":"2012","journal-title":"J Clin Pathol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1089\/lrb.2018.0046","article-title":"Expression of embryonic stem cell markers in microcystic lymphatic malformation","volume":"17","author":"Eady","year":"2019","journal-title":"Lymphat Res Biol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.bjps.2010.08.039","article-title":"Expression of components of the renin\u2013angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution","volume":"64","author":"Itinteang","year":"2011","journal-title":"J Plast Reconstr Aesthetic Surg"},{"key":"B77","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fsurg.2019.00013","article-title":"Expression of components of the renin-angiotensin system in pyogenic granuloma","volume":"6","author":"Papali'i-Curtin","year":"2019","journal-title":"Front Surg"},{"key":"B78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/GOX.0000000000002170","article-title":"Embryonic stem cell-like population within venous malformation expresses the renin\u2013angiotensin system","author":"Tan","year":"2019","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"B79","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fsurg.2016.00024","article-title":"Expression of the components of the renin\u2013angiotensin system in venous malformation","volume":"3","author":"Siljee","year":"2016","journal-title":"Front Surg"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e020","DOI":"10.1097\/JOVA.0000000000000020","article-title":"Expression of angiotensin II receptor 2 in microcystic lymphatic malformation","volume":"2","author":"Siljee","year":"2021","journal-title":"J Vasc Anomalies"},{"key":"B81","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/ajd.12600","article-title":"Consensus statement for the treatment of infantile haemangiomas with propranolol","volume":"58","author":"Smithson","year":"2017","journal-title":"Australas J Dermatol"},{"key":"B82","first-page":"57","article-title":"Steroid therapy for problematic proliferating haemangioma","volume":"124","author":"Tan","year":"2011","journal-title":"N Z Med J"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N Engl J Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/PRS.0b013e3181a3f435","article-title":"Beta-blocking agent for treatment ofinfantile hemangioma","author":"Bigorre","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"B85","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/17512433.2020.1788938","article-title":"\u03b2-blocker therapy for infantile haemangioma","volume":"13","author":"Koh","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/PRS.0b013e31821b63a0","article-title":"Pharmacologic therapies for infantile hemangioma: is there a rational basis?","volume":"128","author":"Itinteang","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"B87","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bjps.2015.10.020","article-title":"Serum levels of renin, angiotensin-converting enzyme and angiotensin II in patients treated by surgical excision, propranolol and captopril for problematic proliferating infantile haemangioma","volume":"69","author":"Sulzberger","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"B88","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1756-8722-4-54","article-title":"Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model","volume":"4","author":"Xu","year":"2011","journal-title":"J Hematol Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jcp.2010.081257","article-title":"Haemogenic endothelium in infantile haemangioma","volume":"63","author":"Itinteang","year":"2010","journal-title":"J Clin Pathol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/jcp.2010.079368","article-title":"Primitive mesodermal cells with a neural crest stem cell phenotype predominate proliferating infantile haemangioma","volume":"63","author":"Itinteang","year":"2010","journal-title":"J Clin Pathol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/jcp.2010.085209","article-title":"Mesenchymal stem cells in infantile haemangioma","volume":"64","author":"Itinteang","year":"2011","journal-title":"J Clin Pathol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/j.1365-2133.2010.10187.x","article-title":"Primitive erythropoiesis in infantile haemangioma","volume":"164","author":"Itinteang","year":"2011","journal-title":"Br J Dermatol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.1182\/blood-2011-12-353466","article-title":"Hemogenic endothelium during development and beyond","volume":"119","author":"Hirschi","year":"2012","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/ng.2331","article-title":"De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes","volume":"44","author":"Rivi\u00e8re","year":"2012","journal-title":"Nat Genet"},{"key":"B95","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41390-019-0430-8","article-title":"Expression of (pro)renin receptor and its effect on endothelial cell proliferation in infantile hemangioma","volume":"86","author":"van Schaijik","year":"2019","journal-title":"Pediatr Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1291\/hypres.30.1139","article-title":"(Pro)renin receptor\u2013mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells","volume":"30","author":"Sakoda","year":"2007","journal-title":"Hypertens Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/hr.2011.113","article-title":"Potential cross-talk between (pro)renin receptors and Wnt\/frizzled receptors in cardiovascular and renal disorders","volume":"34","author":"Balakumar","year":"2011","journal-title":"Hypertens Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/jclinpath-2014-202794","article-title":"Angiotensin II causes cellular proliferation in infantile haemangioma via angiotensin II receptor 2 activation","volume":"68","author":"Itinteang","year":"2015","journal-title":"J Clin Pathol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1136\/bmj.4.5992.316","article-title":"Plasma renin activity and aldosterone concentration in children","volume":"4","author":"Dillon","year":"1975","journal-title":"Br Med J"},{"key":"B100","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF00445660","article-title":"Levels of renin, angiotensin I and II, angiotensin-converting enzyme and aldosterone in infancy and childhood","volume":"141","author":"Fiselier","year":"1983","journal-title":"Eur J Pediatr"},{"key":"B101","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1136\/adc.56.4.298","article-title":"Renin and angiotensin levels in children","volume":"56","author":"Pipkin","year":"1981","journal-title":"Arch Dis Child"},{"key":"B102","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1365-2133.2012.11016.x","article-title":"Treatment of infantile haemangioma with captopril","volume":"167","author":"Tan","year":"2012","journal-title":"Br J Dermatol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fsurg.2015.00026","article-title":"Expression of cathepsins B, D, and G in infantile hemangioma","author":"Itinteang","year":"2015","journal-title":"Front Surg"},{"key":"B104","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/jclinpath-2014-202846","article-title":"Characterisation of subpopulations of myeloid cells in infantile haemangioma","volume":"68","author":"Tan","year":"2015","journal-title":"J Clin Pathol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/01.PRS.0000105683.10752.A6","article-title":"Mast cells and hemangioma","volume":"113","author":"Tan","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"B106","doi-asserted-by":"publisher","first-page":"8","DOI":"10.7554\/eLife.43026","article-title":"R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma","author":"Overman","year":"2019","journal-title":"Elife"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41698-019-0099-9","article-title":"Propranolol exhibits activity against hemangiomas independent of beta blockade","volume":"3","author":"Sasaki","year":"2019","journal-title":"npj Precis Oncol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/CS20110660","article-title":"The renin-angiotensin system, bone marrow and progenitor cells","volume":"123","author":"Durik","year":"2012","journal-title":"Clin Sci"},{"key":"B109","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ajhg.2015.11.011","article-title":"Somatic activating PIK3CA mutations cause venous malformation","volume":"97","author":"Limaye","year":"2015","journal-title":"Am J Hum Genet"},{"key":"B110","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ajhg.2017.01.018","article-title":"Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation","volume":"100","author":"Couto","year":"2017","journal-title":"Am J Hum Genet"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/humu.22431","article-title":"RASA1 mutations and associated phenotypes in 68 families with capillary malformation\u2013arteriovenous malformation","volume":"34","author":"Revencu","year":"2013","journal-title":"Hum Mutat"},{"key":"B112","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/lrb.2020.0047","article-title":"Expression of cathepsins B, D, and G in microcystic lymphatic malformation","volume":"19","author":"Mehrotra","year":"2021","journal-title":"Lymphat Res Biol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fsurg.2021.676871","article-title":"Expression of Cathepsins B, D, and G in extracranial arterio-venous malformation","volume":"8","author":"Hansen","year":"2021","journal-title":"Front Surg"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e022","DOI":"10.1097\/JOVA.0000000000000022","article-title":"Expression of cathepsins B, D, and G in hypertrophic port-wine stain","volume":"2","author":"Koh","year":"2021","journal-title":"J Vasc Anomalies"},{"key":"B115","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","article-title":"Targeted therapy in patients with PIK3CA-related overgrowth syndrome","volume":"558","author":"Venot","year":"2018","journal-title":"Nature"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.jid.2018.03.765","article-title":"Mosaic RAS\/MAPK variants cause sporadic vascular malformations which respond to targeted therapy","volume":"128","author":"Al-Olabi","year":"2018","journal-title":"J Clin Invest"},{"key":"B117","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ajhg.2019.01.015","article-title":"Pharmacodynamic study of miransertib in individuals with proteus syndrome","volume":"104","author":"Keppler-Noreuil","year":"2019","journal-title":"Am J Hum Genet"},{"key":"B118","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/CMR.0000000000000654","article-title":"Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)","volume":"30","author":"Atkinson","year":"2020","journal-title":"Melanoma Res"},{"key":"B119","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1158\/1078-0432.CCR-17-0272","article-title":"Phase Ib\/II study of the safety and efficacy of combination therapy with multikinase vegf inhibitor pazopanib and mek inhibitor trametinib in advanced soft tissue sarcoma","volume":"23","author":"Subbiah","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B120","doi-asserted-by":"publisher","first-page":"529","DOI":"10.25259\/SNI_788_2021","article-title":"Treatment of BRAF V600E mutated ganglioglioma of the third ventricle with dabrafenib","volume":"12","author":"Kilmister","year":"2021","journal-title":"Surg Neurol Int"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.4161\/cbt.8.21.9844","article-title":"High level of AKT activity is associated with resistance to MEK inhibitor AZD6244 (ARRY-142886)","volume":"8","author":"Meng","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"B122","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1158\/0008-5472.CAN-08-4765","article-title":"PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers","volume":"69","author":"Wee","year":"2009","journal-title":"Cancer Res"},{"key":"B123","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/j.1349-7006.2007.00439.x","article-title":"Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis","volume":"98","author":"Kobayashi","year":"2007","journal-title":"Cancer Sci"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1161\/ATVBAHA.109.185918","article-title":"Rapamycin inhibition of the AKT\/mTOR pathway blocks select stages of VEGF-a164-driven angiogenesis, in part by blocking S6kinase","volume":"29","author":"Xue","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1399-3046.2011.01575.x","article-title":"Sirolimus in pediatric renal transplantation","volume":"15","author":"Kasap","year":"2011","journal-title":"Pediatr Transplant"},{"key":"B126","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jvs.2019.06.217","article-title":"Efficacy and safety of sirolimus in the treatment of vascular anomalies: a systematic review","volume":"71","author":"Freixo","year":"2020","journal-title":"J Vasc Surg"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41436-018-0297-9","article-title":"Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum","volume":"21","author":"Parker","year":"2018","journal-title":"Genet Med"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/pbc.23124","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children","volume":"57","author":"Hammill","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"B129","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1101\/gad.297796.117","article-title":"Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescence","volume":"31","author":"Aarts","year":"2017","journal-title":"Genes Dev"},{"key":"B130","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1089\/scd.2019.0188","article-title":"CXCR2 Ligands and mTOR activation enhance reprogramming of human somatic cells to pluripotent stem cells","volume":"29","author":"Lee","year":"2020","journal-title":"Stem Cells Dev"},{"key":"B131","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature20578","article-title":"Inhibition of mTOR induces a paused pluripotent state","volume":"540","author":"Bulut-Karslioglu","year":"2016","journal-title":"Nat"},{"key":"B132","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/cells10030621","article-title":"Cells cancer stem cells: significance in origin, pathogenesis and treatment of glioblastoma","volume":"10","author":"Biserova","year":"2021","journal-title":"Cells"},{"key":"B133","doi-asserted-by":"publisher","first-page":"14759","DOI":"10.1002\/jcp.28271","article-title":"Current approaches in identification and isolation of cancer stem cells","volume":"234","author":"Akbarzadeh","year":"2019","journal-title":"J Cell Physiol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1749-6632.2009.04568.x","article-title":"Antitumor immunity and cancer stem cells","volume":"1176","author":"Schatton","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"B135","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3390\/cancers11030345","article-title":"Conversion of stem cells to cancer stem cells: undercurrent of cancer initiation","volume":"11","author":"Afify","year":"2019","journal-title":"Cancers"},{"key":"B136","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/biomedicines6030077","article-title":"Breast cancer stem cells","volume":"6","author":"Crabtree","year":"2018","journal-title":"Biomed"},{"key":"B137","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/path.2478","article-title":"Prostate cancer stem cells","volume":"217","author":"Lang","year":"2009","journal-title":"J Pathol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40880-017-0206-7","article-title":"Cancer metastasis: issues and challenges","volume":"36","author":"Qian","year":"2017","journal-title":"Chin J Cancer"},{"key":"B139","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbcan.2018.10.006","author":"Nimmakayala","year":"2019","journal-title":"Unraveling the journey of cancer stem cells from origin to metastasis"},{"key":"B140","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"key":"B141","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0002-9440(10)65628-3","article-title":"Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases","volume":"153","author":"Luzzi","year":"1998","journal-title":"Am J Pathol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/jcp.25759","article-title":"Isolation, identification, and characterization of cancer stem cells: a review","volume":"232","author":"Abbaszadegan","year":"2017","journal-title":"J Cell Physiol"},{"key":"B143","first-page":"46","article-title":"Metastatic cancer stem cells: from the concept to therapeutics","volume":"3","author":"Liao","year":"2014","journal-title":"Am J Stem Cells"},{"key":"B144","doi-asserted-by":"publisher","first-page":"e62493","DOI":"10.1371\/journal.pone.0062493","article-title":"Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism","volume":"8","author":"Gammon","year":"2013","journal-title":"PLoS ONE"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/nm0909-1010","article-title":"Cancer stem cells: mirage or reality?","volume":"15","author":"Gupta","year":"2009","journal-title":"Nat Med"},{"key":"B146","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.devcel.2018.05.025","article-title":"Regulation of epithelial plasticity determines metastatic organotropism in pancreatic cancer","volume":"45","author":"Reichert","year":"2018","journal-title":"Dev Cell"},{"key":"B147","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semcancer.2012.03.002","article-title":"Cancer stem cells and metastasis","volume":"22","author":"Sampieri","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","article-title":"Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer","volume":"1","author":"Hermann","year":"2007","journal-title":"Cell Stem Cell"},{"key":"B149","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1445-2197.2010.05583.x","article-title":"Changing incidence of non-melanoma skin cancer in New Zealand","volume":"81","author":"Brougham","year":"2011","journal-title":"ANZ J Surg"},{"key":"B150","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/jso.23155","article-title":"The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors","volume":"106","author":"Brougham","year":"2012","journal-title":"J Surg Oncol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/jso.23731","article-title":"The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma\u2013implications on the T-classification system","volume":"110","author":"Brougham","year":"2014","journal-title":"J Surg Oncol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/01.PRS.0000138243.45735.8A","article-title":"Squamous cell carcinoma of the skin","author":"Rudolph","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"B153","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.trre.2009.02.004","article-title":"Skin cancer after transplantation","volume":"23","author":"Kovach","year":"2009","journal-title":"Transplant Rev"},{"key":"B154","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/jso.21092","article-title":"Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma","volume":"98","author":"Ch'ng","year":"2008","journal-title":"J Surg Oncol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"5799","DOI":"10.1038\/s41388-021-01973-5","article-title":"MiR-22 promotes stem cell traits via activating Wnt\/\u03b2-catenin signaling in cutaneous squamous cell carcinoma","volume":"40","author":"Yuan","year":"2021","journal-title":"Oncogene"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.bjps.2018.11.013","article-title":"Cancer stem cells within moderately differentiated head and neck cutaneous squamous cell carcinoma express components of the renin-angiotensin system","volume":"72","author":"Nallaiah","year":"2019","journal-title":"J Plast Reconstr Aesthetic Surg"},{"key":"B157","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/healthcare2010001","article-title":"Malignant melanoma","volume":"2","author":"Perera","year":"2013","journal-title":"Healthc"},{"key":"B159","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/00000658-200206000-00017","article-title":"Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis","volume":"235","author":"White","year":"2002","journal-title":"Ann Surg"},{"key":"B160","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/hed.2890080412","article-title":"Melanoma of the upper aerodigestive tract: A review of 21 cases","volume":"8","author":"Panje","year":"1986","journal-title":"Head Neck Surg"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1001\/archotol.1987.01860100064023","article-title":"Melanoma of the nasal and paranasal sinus mucosa","volume":"113","author":"Trapp","year":"1987","journal-title":"Arch Otolaryngol Neck Surg"},{"key":"B162","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng.1041","article-title":"Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing","volume":"44","author":"Stark","year":"2011","journal-title":"Nat Genet"},{"key":"B163","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N Engl J Med"},{"key":"B164","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"B165","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"B166","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1158\/1078-0432.CCR-18-1550","article-title":"Immunotherapy of melanoma: facts and hopes","volume":"25","author":"Weiss","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B167","doi-asserted-by":"publisher","first-page":"e1097","DOI":"10.1097\/MD.0000000000001097","article-title":"Propranolol reduces cancer risk: a population-based cohort study","volume":"94","author":"Chang","year":"2015","journal-title":"Medicine"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-19-2641","article-title":"Preoperative \u03b2-blockade with propranolol reduces biomarkers of metastasis in breast cancer: a phase II randomized trial","volume":"26","author":"Hiller","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1158\/1078-0432.CCR-11-0641","article-title":"Molecular pathways: beta-adrenergic signaling in cancer","volume":"18","author":"Cole","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.3390\/ijms21041420","article-title":"\u03b23- Adrenoreceptor blockade induces stem cells differentiation in melanoma microenvironment","volume":"21","author":"Calvani","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B171","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/life10110268","article-title":"Cancer stem cells in head and neck metastatic malignant melanoma express components of the renin-angiotensin system","volume":"10","author":"Siljee","year":"2020","journal-title":"Life"},{"key":"B172","doi-asserted-by":"publisher","first-page":"62","DOI":"10.20517\/2394-4722.2019.009","article-title":"Cancer stem cell subpopulations in metastatic melanoma to the brain express components of the renin-angiotensin system","volume":"5","author":"Wickremesekera","year":"2019","journal-title":"J Cancer Metastasis Treat"},{"key":"B173","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bcp.2018.04.012","article-title":"Angiotensin II promotes pulmonary metastasis of melanoma through the activation of adhesion molecules in vascular endothelial cells","volume":"154","author":"Ishikane","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s00432-021-03612-8","article-title":"CCL5 production by fibroblasts through a local renin\u2013angiotensin system in malignant melanoma affects tumor immune responses","volume":"147","author":"Nakamura","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1038\/s41388-018-0563-y","article-title":"The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention","volume":"38","author":"Renziehausen","year":"2019","journal-title":"Oncogene"},{"key":"B176","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","article-title":"Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?","volume":"352","author":"Lever","year":"1998","journal-title":"Lancet"},{"key":"B177","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/MD.0000000000006394","article-title":"Do renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: evidence from a meta-analysis including 55 studies","author":"Sun","year":"2017","journal-title":"Medicine"},{"key":"B178","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1470320316656679","article-title":"Renin-angiotensin system blockade for the risk of cancer and death","author":"Shen","year":"2016","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"B179","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/MD.0000000000019075","article-title":"The renin-angiotensin system blockers and survival in digestive system malignancies: a systematic review and meta-analysis","author":"Zhou","year":"2020","journal-title":"Med"},{"key":"B180","first-page":"1375","article-title":"The renin-angiotensin system blockers as adjunctive therapy for cancer: a meta-analysis of survival outcome","volume":"21","author":"Li","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B181","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1470-2045(10)70106-6","article-title":"Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials","volume":"11","author":"Sipahi","year":"2010","journal-title":"Lancet Oncol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1002\/1097-0142(20011101)92:9<2462::AID-CNCR1596>3.0.CO;2-L","article-title":"Angiotensin-converting enzyme inhibitors and the risk of cancer a population-based cohort study in denmark","volume":"92","author":"Friis","year":"2001","journal-title":"Cancer"},{"key":"B183","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/HJH.0b013e328344a7de","article-title":"Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals","volume":"29","author":"Teo","year":"2011","journal-title":"J Hypertens"},{"key":"B184","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bcp.2018.03.008","article-title":"The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasis","volume":"151","author":"Ishikane","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/path.1529","article-title":"Linkage of angiotensin I-converting enzyme gene insertion\/deletion polymorphism to the progression of human prostate cancer","volume":"202","author":"Medeiros","year":"2004","journal-title":"J Pathol"},{"key":"B186","doi-asserted-by":"publisher","first-page":"e0256280","DOI":"10.1371\/journal.pone.0256280","article-title":"Colon adenocarcinoma-derived cells possessing stem cell function can be modulated using renin-angiotensin system inhibitors","volume":"16","author":"Munro","year":"2021","journal-title":"PLoS ONE"},{"key":"B187","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jocn.2021.11.023","article-title":"Treatment of glioblastoma with re-purposed renin-angiotensin system modulators: Results of a phase I clinical trial","volume":"95","author":"O'Rawe","year":"2022","journal-title":"J Clin Neurosci"},{"key":"B188","doi-asserted-by":"publisher","first-page":"8052","DOI":"10.18632\/oncotarget.2408","article-title":"CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide","volume":"5","author":"Kast","year":"2014","journal-title":"Oncotarget"},{"key":"B189","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1681\/ASN.2009080872","article-title":"Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system","volume":"21","author":"Zhang","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00403-009-1014-y","article-title":"Genetics of keloid scarring","volume":"302","author":"Shih","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"B191","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1097\/GOX.0b013e31829c4597","article-title":"Keloids and hypertrophic scars: update and future directions","volume":"1","author":"Huang","year":"2013","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"B192","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1097\/PRS.0000000000006275","article-title":"Expression of cathepsins B, D, and G by the embryonic stem cell-like population within human keloid tissues and keloid-derived primary cell lines","volume":"144","author":"Paterson","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"B193","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1371\/journal.pone.0007798","article-title":"Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17\/IL-6 axis","author":"Zhang","year":"2009","journal-title":"PLoS ONE"},{"key":"B194","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/PRS.0000000000005867","article-title":"Expression of components of the renin-angiotensin system by the embryonic stem cell-like population within keloid lesions","volume":"144","author":"Humphries","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"B195","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.jhh.1001960","article-title":"RAS inhibition in hypertension","volume":"20","author":"Ibrahim","year":"2006","journal-title":"J Hum Hypertens"},{"key":"B196","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1046\/j.1523-1755.1998.00164.x","article-title":"Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade","volume":"54","author":"Peters","year":"1998","journal-title":"Kidney Int"},{"key":"B197","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/08037050310001057","article-title":"Angiotensin AT1\/AT2 receptors: regulation, signalling and function","volume":"12","author":"Kaschina","year":"2003","journal-title":"Blood Press"},{"key":"B198","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3945\/jn.109.115253","article-title":"Vitamin D intake needed to maintain target serum 25-hydroxyvitamin S concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations","volume":"140","author":"Hall","year":"2010","journal-title":"J Nutr"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-03474-6","article-title":"Chronic vitamin D deficiency induces lung fibrosis through activation of the renin-angiotensin system","volume":"7","author":"Shi","year":"2017","journal-title":"Sci Reports"},{"key":"B200","doi-asserted-by":"publisher","first-page":"F1107","DOI":"10.1152\/ajprenal.00151.2012","article-title":"Loss of vitamin D receptor in chronic kidney disease: a potential mechanism linking inflammation to epithelial-to-mesenchymal transition","volume":"303","author":"Xiong","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"B201","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13069-015-0023-z","article-title":"Modulation of angiotensin II signaling in the prevention of fibrosis","volume":"8","author":"Murphy","year":"2015","journal-title":"Fibrogenes Tissue Repair"},{"key":"B202","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1475-2840-9-31","article-title":"Angiotensin II mediates the high-glucose-induced endothelial-to-mesenchymal transition in human aortic endothelial cells","volume":"9","author":"Tang","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1054\/plef.2000.0207","article-title":"Keloids in rural black South Africans. Part 1: general overview and essential fatty acid hypotheses for keloid formation and prevention","volume":"63","author":"Louw","year":"2000","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B204","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1126\/science.6251551","article-title":"Photosynthesis of previtamin D3 in human skin and the physiologic consequences","volume":"210","author":"Holick","year":"1980","journal-title":"Science"},{"key":"B205","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/wrr.12277","article-title":"Hypertension: a systemic key to understanding local keloid severity","volume":"23","author":"Arima","year":"2015","journal-title":"Wound Repair Regen"},{"key":"B206","doi-asserted-by":"publisher","first-page":"331","DOI":"10.5114\/ceji.2018.80053","article-title":"The immunological implication of the new vitamin D metabolism","volume":"43","author":"Bivona","year":"2018","journal-title":"Cent J Immunol"},{"key":"B207","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1210\/jcem-68-5-882","article-title":"Sunlight regulates the cutaneous production of vitamin d3 by causing its photodegradation","volume":"68","author":"Webb","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"B208","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00223-012-9619-0","article-title":"Molecular mechanisms of vitamin D action","volume":"92","author":"Haussler","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"B209","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1210\/jc.2008-1454","article-title":"Nonclassic actions of vitamin D","volume":"94","author":"Bikle","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B210","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.beem.2011.05.010","article-title":"Vitamin D receptor (VDR)-mediated actions of 1\u03b1,25(OH)2vitamin D3: genomic and non-genomic mechanisms","volume":"25","author":"Haussler","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B211","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3390\/ijms19061672","article-title":"Vitamin D receptor is necessary for mitochondrial function and cell health","volume":"19","author":"Ricca","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B212","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mce.2017.02.046","article-title":"Structural aspects of Vitamin D endocrinology","volume":"453","author":"Rochel","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"B213","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/bjs.7307","article-title":"Characterization of stem cells in Dupuytren's disease","volume":"98","author":"Hindocha","year":"2011","journal-title":"Br J Surg"},{"key":"B214","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s11552-008-9160-9","article-title":"Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology","volume":"4","author":"Hindocha","year":"2009","journal-title":"Hand (N Y)"},{"key":"B215","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1302\/0301-620X.82B1.0820090","article-title":"Dermofasciectomy in the management of Dupuytren's disease","volume":"82","author":"Armstrong","year":"2000","journal-title":"J Bone Joint Surg Br"},{"key":"B216","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren's contracture","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"key":"B217","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1089\/scd.2011.0140","article-title":"Identification of mesenchymal stem cells in perinodular fat and skin in dupuytren's disease: a potential source of myofibroblasts with implications for pathogenesis and therapy","volume":"21","author":"Iqbal","year":"2012","journal-title":"Stem Cells Dev"},{"key":"B218","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/2000656X.2017.1319846","article-title":"Angiotensin receptors in Dupuytren's disease: a target for pharmacological treatment?","volume":"52","author":"Stephen","year":"2018","journal-title":"J Plast Surg Hand Surg"},{"key":"B219","doi-asserted-by":"publisher","first-page":"105595","DOI":"10.1016\/j.biocel.2019.105595","article-title":"Fibrocytes and fibroblasts\u2014Where are we now","volume":"116","author":"Chong","year":"2019","journal-title":"Int J Biochem Cell Biol"},{"key":"B220","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/GOX.0000000000001686","article-title":"Expression and localization of cathepsins B, D, and G in Dupuytren's disease","author":"Tan","year":"2018","journal-title":"Plast Reconstr Surg. Glob Open"},{"key":"B221","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.exphem.2010.03.004","article-title":"Fibrocytes in health and disease","volume":"38","author":"Herzog","year":"2010","journal-title":"Exp Hematol"},{"key":"B222","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/wrr.12648","article-title":"Losartan ointment relieves hypertrophic scars and keloid: A pilot study","volume":"26","author":"Hedayatyanfard","year":"2018","journal-title":"Wound Repair Regen"},{"key":"B223","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/PRS.0b013e31819a34db","article-title":"Treatment of a postburn keloid scar with topical captopril: report of the first case","author":"Ardekani","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"B224","first-page":"60","article-title":"Low-dose enalapril in the treatment of surgical cutaneous hypertrophic scar and keloid - two case reports and literature review","volume":"8","author":"Iannello","year":"2006","journal-title":"Medscape Gen Med"},{"key":"B225","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/1470320313496858","article-title":"The renin-angiotensin system meets the hallmarks of cancer","volume":"16","author":"Wegman-Ostrosky","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"B226","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00213-8","article-title":"Overcoming cancer therapeutic bottleneck by drug repurposing","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct Target Ther"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.868187\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T17:40:46Z","timestamp":1675446046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.868187\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":226,"alternative-id":["10.3389\/fsurg.2022.868187"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2022.868187","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"article-number":"868187"}}